By Chris Matheus 2024 Year-End Review As we close out 2024, we look back and note the adjustments and enhancements we have made to our network of clinical research services in support of clinical trials efficiency. This year has been a testament to the power of persistence and commitment to our mission. We’re proud to… Read more »
Category: GLSA News
Dispelling the Myth: Plug-and-Play Solutions in Clinical Trials
At the 11th Annual Outsourcing in Clinical Trials Nordics meeting in Copenhagen, a prevailing theme emerged – the importance of responsibility, transparency, and accountability in the relationship between contract research organizations (CROs) and sponsors. One key sentiment echoed by a speaker was the belief that there are no plug-and-play methods for outsourcing. We respectfully disagree.… Read more »
GLSA Year in Review: Navigating Challenges and Celebrating Connections in 2023
As we look back in our rear view mirrors at 2023, it’s a good time to reflect on the year and acknowledge the dedication and effort required in the drug development industry. Adapting to the challenges that the industry faced, GLSA proved to be flexible in adapting to the changes and continuing to focus on… Read more »
GLSA’s Industry of the Year 2020
Without a doubt the work done by the pharmaceutical, biotech, clinical research, drug development industry and the Food and Drug Administration is worthy of this distinction for 2020. What was accomplished is just short of miraculous. The federal government (FDA) and the corporations cut no corners. I have no doubt that everything was done according… Read more »
Alliance opens new BD route to the US for UK Life Sciences Companies
The Covid-19 crisis presents us with many challenges. One of the more frustrating for business development professionals and owners of companies for whom market engagement is key is not being able to meet the customer. The US is the biggest market in the world and yet we cannot get there. Not physically, and not for… Read more »